§ Funding Round
Series C funding round for ACELYRIN raising $300M in September 2022
Series C funding round for ACELYRIN raising $300M in September 2022
| Investor | Firm Type | Partner |
|---|---|---|
Access BiotechnologyLEAD | — | — |
| Organization | — | |
Contrary Capital | — | — |
| Organization | — | |
| Angel | matthew mcaviney | |
| Angel | robert garland | |
| Organization | — | |
Westlake Village BioPartners | — | — |
| Angel | ron pragides | |
| Organization | — | |
Cowen Healthcare Investments | — | — |
| Organization | — | |
Marshall Wace | — | — |
| Organization | — | |
Samsara BioCapital | — | — |
Surveyor Capital | — | — |
| Organization | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$758M
Top Valuation
-
ACELYRIN raised $300M in a Series C round.
The round was announced on 09/01/22.
The round was led by Access Biotechnology.
